首页> 外国专利> Antagonists of the transcription factor c-maf Short Form for the treatment of glaucoma

Antagonists of the transcription factor c-maf Short Form for the treatment of glaucoma

机译:转录因子c-maf Short Form的拮抗剂治疗青光眼

摘要

The form of the shortened version of facator c-maf Transcription is up regulated in the trabecular meshwork cells treated with steroids or treated with transforming growth factor beta, and is present in niveleselevados normal trabecular meshwork cells against the affected by G Laucoma and Brain tissue of normal and glaucomatous optic nerve.The expression of the transcription factor c-maf Short Form under these Conditions indicates a role for the effector or causal factor in the Pathogenesis of Primary open-angle glaucoma or induced by steroids.The antagonism of the expression or activity of the transcription factor c-maf Short Form in the trabecular meshwork or other ocular Tissue is provided to inhibit or alleviate the Pathogenesis of glaucoma. Antagonists include inhibitors of Cyclin Dependent Kinase 2.
机译:Facator c-maf Transcription的缩短形式在用类固醇或转化生长因子β处理的小梁网细胞中被上调,并存在于niveleselevados正常小梁网细胞中,以对抗G型青光眼和脑组织的影响在这种情况下转录因子c-maf短形式的表达表明效应子或因果因子在原发性开角型青光眼发病或类固醇诱导中的作用。表达或活性的拮抗作用在小梁网或其他眼组织中提供转录因子c-maf Short Form的形式以抑制或减轻青光眼的发病机理。拮抗剂包括细胞周期蛋白依赖性激酶2的抑制剂。

著录项

  • 公开/公告号UY28660A1

    专利类型

  • 公开/公告日2005-07-29

    原文格式PDF

  • 申请/专利权人 ALCON INC.;

    申请/专利号UY20040028660

  • 申请日2004-12-08

  • 分类号A61P27/06;

  • 国家 UY

  • 入库时间 2022-08-21 22:16:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号